The Hungarian Pancreatic Study Group (HPSG) was established with the aim of advancing
pancreatology. Our summary outlines the methodologies, key results, and future directions
of the HPSG. Methodological elements included, the formation of strategic national
and international collaborations, the establishment of patient registries and biobanks,
and a strong focus on education and guideline development. Key results encompassed,
pioneering research on pancreatic ductal function and the role of cystic fibrosis
transmembrane conductance regulator (CFTR) in inflammation, significant advancements
in understanding acute and chronic pancreatitis, and the execution of numerous clinical
trials to explore new therapeutic approaches. Despite challenges, such as securing
funding and translating research into clinical practice, the HPSG’s commitment to
patient care and scientific innovation has been unwavering. The group aims to deepen
research into pancreatic cancer and chronic pancreatitis, conduct more randomized
controlled trials (RCTs), and expand its efforts internationally by involving global
staff and patients. The authors hope that this summary inspires others to undertake
similar initiatives and contribute to the global advancement of medical research and
patient care in pancreatology.